Additional Risk Minimisation Measures for Medicinal Products in the European Union: A Review of the Implementation and Effectiveness of Measures in the United Kingdom by One Marketing Authorisation Holder

INTRODUCTION: Additional risk minimisation measures (aRMMs) for medicinal products are necessary to address specific important safety issues which may not be practically achieved through routine risk management measures alone. The implementation and determination of effectiveness for aRMMs can be a...

Descripción completa

Detalles Bibliográficos
Autores principales: Agyemang, Elaine, Bailey, Lorna, Talbot, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376384/
https://www.ncbi.nlm.nih.gov/pubmed/28413313
http://dx.doi.org/10.1007/s40290-017-0184-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376384/
https://www.ncbi.nlm.nih.gov/pubmed/28413313
http://dx.doi.org/10.1007/s40290-017-0184-8

Ejemplares similares